Journal
JOURNAL OF IMMUNOLOGY
Volume 179, Issue 3, Pages 1648-1658Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.179.3.1648
Keywords
-
Categories
Funding
- NCRR NIH HHS [RR00059, M01 RR000059] Funding Source: Medline
- NHLBI NIH HHS [R01 HL079901, HL-077431, R01 HL077431, K08 HL089392, R01 HL079901-05, HL079901-01A1, HL-60316] Funding Source: Medline
- NIAID NIH HHS [AI063502] Funding Source: Medline
Ask authors/readers for more resources
Respiratory syncytial virus (RSV) is a ubiquitous virus that preferentially infects airway epithelial cells, causing asthma exacerbations and severe disease in immunocompromised hosts. Acute RSV infection induces inflammation in the lung. Thymus- and activation-regulated chemokine (TARC) recruits Th2 cells to sites of inflammation. We found that acute RSV infection of BALB/c mice increased TARC production in the lung. Immunization of BALB/c mice with individual RSV proteins can lead to the development of Th1- or Th2-biased T cell responses in the lung after RSV infection. We primed animals with a recombinant vaccinia virus expressing either the RSV fusion (F) protein or the RSV attachment (G) protein, inducing Th1- and Th2-biased pulmonary memory T cell responses, respectively. After RSV infection, TARC production significantly increased in the vaccinia virus G-primed animals only. These data suggest a positive feedback loop for TARC production between RSV infection and Th2 cytokines. RSV-infected lung epithelial cells cultured with IL-4 or IL-13 demonstrated a marked increase in the production of TARC. The synergistic effect of RSV and IL-4/IL-13 on TARC production reflected differential induction of NF kappa B and STAT6 by the two stimuli (both are in the TARC promoter). These findings demonstrate that RSV induces a chemokine TARC that has the potential to recruit Th2 cells to the lung.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available